These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28598267)

  • 1. Interaction of Immunoglobulin with Cytomegalovirus-Infected Cells.
    Aiba N; Shiraki A; Yajima M; Oyama Y; Yoshida Y; Ohno A; Yamada H; Takemoto M; Daikoku T; Shiraki K
    Viral Immunol; 2017 Sep; 30(7):500-507. PubMed ID: 28598267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional differences between antiviral activities of sulfonated and intact intravenous immunoglobulin preparations toward varicella-zoster virus and cytomegalovirus.
    Yajima M; Shiraki A; Daikoku T; Oyama Y; Yoshida Y; Shiraki K
    J Infect Chemother; 2015 Jun; 21(6):427-33. PubMed ID: 25824903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of cytomegalovirus (CMV)-specific neutralization capacity of hyperimmunoglobulin (HIG) versus standard intravenous immunoglobulin (IVIG) preparations: Impact of CMV IgG normalization.
    Schampera MS; Schweinzer K; Abele H; Kagan KO; Klein R; Rettig I; Jahn G; Hamprecht K
    J Clin Virol; 2017 May; 90():40-45. PubMed ID: 28342316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus neutralization by hyperimmune and standard intravenous immunoglobulin preparations.
    Planitzer CB; Saemann MD; Gajek H; Farcet MR; Kreil TR
    Transplantation; 2011 Aug; 92(3):267-70. PubMed ID: 21659947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Properties of Human Cytomegalovirus Hyperimmunoglobulin and Standard Immunoglobulin Preparations.
    Germer M; Herbener P; Schüttrumpf J
    Ann Transplant; 2016 Sep; 21():558-64. PubMed ID: 27595792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serology indicates cytomegalovirus infection is associated with varicella-zoster virus reactivation.
    Ogunjimi B; Theeten H; Hens N; Beutels P
    J Med Virol; 2014 May; 86(5):812-9. PubMed ID: 24037981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral function and efficacy of polyvalent immunoglobulin products against CMV isolates in different human cell lines.
    Frenzel K; Ganepola S; Michel D; Thiel E; Krüger DH; Uharek L; Hofmann J
    Med Microbiol Immunol; 2012 Aug; 201(3):277-86. PubMed ID: 22297735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus Humoral Response Against Epithelial Cell Entry-Mediated Infection in the Primary Infection Setting After Hematopoietic Cell Transplantation.
    Zamora D; Krantz EM; Green ML; Joncas-Schronce L; Blazevic R; Edmison BC; Huang ML; Stevens-Ayers T; Jerome KR; Geballe AP; Boeckh M
    J Infect Dis; 2020 Apr; 221(9):1470-1479. PubMed ID: 31734696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro evaluation of cytomegalovirus-specific hyperimmune globulins vs. standard intravenous immunoglobulins.
    Miescher SM; Huber TM; Kühne M; Lieby P; Snydman DR; Vensak JL; Berger M
    Vox Sang; 2015 Jul; 109(1):71-8. PubMed ID: 25766313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of pentamer complex-specific and IgG subclass 3 antibodies in HCMV hyperimmunoglobulin and standard intravenous IgG preparations.
    Schampera MS; Arellano-Galindo J; Kagan KO; Adler SP; Jahn G; Hamprecht K
    Med Microbiol Immunol; 2019 Feb; 208(1):69-80. PubMed ID: 30203132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative EBV antibody concentrations and cost of standard IVIG and CMV-IVIG for PTLD prophylaxis in solid organ transplant patients.
    Ramirez-Avila L; Garner OB; Cherry JD
    Pediatr Transplant; 2014 Sep; 18(6):599-601. PubMed ID: 25041939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An enzyme immunoassay based micro-neutralization test for titration of antibodies to human cytomegalovirus (CMV) and its correlation with direct ELISA measuring CMV IgG antibodies.
    Gupta CK; Leszczynski J; Gupta RK; Siber GR
    Biologicals; 1996 Mar; 24(1):41-9. PubMed ID: 8733600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dimerized single-chain variable fragment system for the assessment of neutralizing activity of phage display-selected antibody fragments specific for cytomegalovirus.
    Carlsson F; Trilling M; Perez F; Ohlin M
    J Immunol Methods; 2012 Feb; 376(1-2):69-78. PubMed ID: 22154743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Cytomegalovirus Particles Treated with Specific Antibodies Induce Intrinsic and Adaptive but Not Innate Immune Responses.
    Wu Z; Qin R; Wang L; Bosso M; Scherer M; Stamminger T; Hotter D; Mertens T; Frascaroli G
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement and assessment of cytomegalovirus of immunoglobulin (Ig) g titer in preparations.
    Shibaguchi H; Yamamoto T; Kuroki M; Futagami K
    Yakugaku Zasshi; 2010 Jul; 130(7):977-82. PubMed ID: 20606378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serologic follow-up of cytomegalovirus, herpes simplex and varicella-zoster infections in kidney transplant recipients].
    Merlino C
    G Batteriol Virol Immunol; 1991; 84(1-12):41-52. PubMed ID: 1668971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding and neutralizing anti-cytomegalovirus activities in immune globulin products.
    Wang X; Xu Y; Scott DE; Murata H; Struble EB
    Biologicals; 2017 Nov; 50():35-41. PubMed ID: 29029807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a high-throughput assay to measure the neutralization capability of anti-cytomegalovirus antibodies.
    Gardner TJ; Bolovan-Fritts C; Teng MW; Redmann V; Kraus TA; Sperling R; Moran T; Britt W; Weinberger LS; Tortorella D
    Clin Vaccine Immunol; 2013 Apr; 20(4):540-50. PubMed ID: 23389931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human cytomegalovirus escapes a naturally occurring neutralizing antibody by incorporating it into assembling virions.
    Manley K; Anderson J; Yang F; Szustakowski J; Oakeley EJ; Compton T; Feire AL
    Cell Host Microbe; 2011 Sep; 10(3):197-209. PubMed ID: 21925108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus Virions Shed in Urine Have a Reversible Block to Epithelial Cell Entry and Are Highly Resistant to Antibody Neutralization.
    Cui X; Adler SP; Schleiss MR; Arav-Boger R; Demmler Harrison GJ; McVoy MA
    Clin Vaccine Immunol; 2017 Jun; 24(6):. PubMed ID: 28404573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.